<?xml version="1.0" encoding="ISO-8859-1"?>
<?xml-stylesheet type="text/xsl" href="helma.xsl"?>
<xmlroot xmlns:hop="http://www.helma.org/docs/guide/features/database">
  <hopobject id="2432" name="Page" prototype="Page" created="1363280116832" lastModified="1542978561693">
  <hop:parent idref="0" prototyperef="Root"/>
    <http_browser>Mozilla/4.0 (compatible; MSIE 6.0; Windows NT 5.1; SV1)</http_browser>
    <lang>en-us</lang>
    <uri>bone-update</uri>
    <http_host>127.0.0.1:8080</http_host>
    <time type="date">23.11.2018 13:09:21 UTC</time>
    <pseudoparent idref="0" prototyperef="Root"/>
    <http_remotehost>127.0.0.1</http_remotehost>
    <hopsession>127.0.0.1wjlur3zwx2yz</hopsession>
    <user>default</user>
    <pvcount type="float">85.0</pvcount>
    <body>I&apos;m self-employed &lt;a href=&quot;http://nous.name/how-much-trazodone-does-it-take-to-sleep/&quot;&gt;trazodone sleep disorders&lt;/a&gt;  The absence of economic incentives for drugmakers to develop and supply medicines for neglected tropical diseases (NTDs) has long been highlighted by health campaigners, but it rarely gets on to the political radar in the West.
 </body>
    <http_language>en-US,en;q=0.8</http_language>
    <is_xhtml type="boolean">true</is_xhtml>
    <http_referer>http://beagleboard.org/bone-update/edit</http_referer>
  </hopobject>
</xmlroot>
